Collectively, the above mentioned findings indicate that NRP-1 is a crucial regulator in breast cancer pathogenesis and might be responsible for the chemoresistance medicated by RP11-70C1.3/miR-6736-3p. This evidence concerns the gene NRP1 and breast cancer.